Anti-leukemic activity of phosphoproteins from Sesamin via induction of nuclear antigen H731and CLIP-associating protein 2 isoform X25 mediated apoptosis
Keywords:
Leukemia, Sesamin, Apoptosis, Phosphoprotein, Mass spectrometryAbstract
Leukemia is an uncontrolled proliferation hematopoietic cancer cells that commonly treats with conventional therapies such as chemotherapy. However, many side effects were reported. Alternative medicines have been developed by using natural or herb compounds as therapeutic drug. Sesamin, a class of phytoestrogen isolated from sesame seed displaying potent anticancer activity in vitro and in vivo.However, the mechanism by which sesamin mediates anticancer effects on leukemic cells are notfully understood. In thisstudy, the effects of sesamin on cell viability, cell apoptosis and expression of phosphoproteins in Molt-4 and NB4 leukemic cell lines were investigated using MTT assay, flow cytometry and immobilized metal affinity chromatography (IMAC) phosphoprotein enrichment and LC-MS, respectively. The results showed that sesamin reduced viability and induced apoptosis in leukemic cells. In addition, 79 phosphoproteins were identified from LC-MS within three main clusters including biological regulation, cellular processand metabolic process. Interestingly, nuclear antigen H731 (PDCD4) and CLIP-associating protein 2 isoform X25 (CLASP2) showed increased in sesamin treated cells and associated protein-ligand interaction network with allicin, capsaicin, cucurbitacin B, and rapamycin which are known to activate apoptosis in cancer cells.Then, sesamin could be developed as candidate of alternative leukemia treatment in the future.
References
Leukemia & Lymphoma Society., 2013. FACTS (2013). White Plains, NY: Leukemia & Lymphoma Society. 2. Polychronakis I, Dounias G, Makropoulos V, Riza E, Linos A., (2013). Work-related leukemia: a systematic review. J Occup Med Toxicol. 8, 14. 3. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al., (2009). The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 114, 937-51. 4.Kaefer CM, Milner JA., (2011). Herbs and Spices in Cancer Prevention and Treatment. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. Boca Raton FL: Llc. 5. Dar AA, Arumugam N., (2013). Lignans of sesame: purification methods, biological activities and biosynthesis--a review. Bioorg Chem. 50, 1-10. 6. Kanu PJ BJ, Kanu JB, Kandeh JBA., (2010). Nutraceutical Importance of Sesame Seed and Oil: A Review of the Contribution of their Lignans. Sierra Leone J Biomed Res. 2, 4-16. 7. Siao AC, Hou CW, Kao YH, Jeng KC., (2015). Effect of sesamin on apoptosis and cell cycle arrest in human breast cancer mcf-7 cells. Asian Pac J Cancer Prev. 16, 3779-83. 8. Deng P, Wang C, Chen L, Wang C, Du Y, Yan X, et al., (2013). Sesamin induces cell cycle arrest and apoptosis through the inhibition of signal transducer and activator of transcription 3 signalling in human hepatocellular carcinoma cell line HepG2. Biol Pharm Bull. 36, 1540-8. 9. Harsha HC and Pandey A., (2010).Phosphoproteomics in cancer.MolOncol. 4, 482–495. 10. Hunter T., (1995). Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell.80, 225–236. 11. Johnson GL and Lapadat R., (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science.298,1911–1912. 12. Lowry OH, Rosbrough NJ, Farr AL, and Randall RJ., (1951).Protein measurement with the folinphenolreagent.J Biol Chem. 193, 265. 13. Mi H, Muruganujan A, Casagrande JT, Thomas PD., (2013). Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 8, 1551-66. 14. Bhatia V.N., Perlman D.H., Costello C.E., McComb M.E., (2009). Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal. Chem. 81, 9819–9823. 15. Kuhn M, Szklarczyk D, Pletscher-Frankild S, et al., (2014). STITCH 4: integration of protein-chemical interactions with user data. Nucleic Acids Res. 42, (Database issue):D401-D407. 16. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M., (2006). S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science. 314, 467-71. 17. Ozpolat B, Akar U, Steiner M, Zorrilla-Calancha I, Tirado-Gomez M, Colburn N, et al., (2007). Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol Cancer Res. 5, 95-108. 18. Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, Cheung AN, et al., 2009. Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol Cancer. 8, 70. 19. Jansen AP, Camalier CE, Stark C, Colburn NH., (2004). Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther. 3, 103-10. 20. Douros J, Suffness M., 1981.New antitumor substances of natural origin. Cancer Treat Rev.8, 63–87. 21. Faivre S, Kroemer G, Raymond E., (2006).Current development of mTOR inhibitors as anticancer agents.Nat Rev Drug Discov.5, 671-88. 22.Wang Z, Xu F, Yuan N, Niu Y, Lin W, Cao Y, Cai J, Song L, Li X, Fang Y, Zhao W, Hu S, Chen S, Zhang S, Wang J., 2014. Rapamycin inhibits pre-B acute lymphoblastic leukemia cells by downregulating DNA and RNA polymerases. Leukemia Res. 38, 940-947 23.Avellino R, Romano S, Parasole R, Bisogni R, Lamberti A, Poggi V, Venuta S, Romano MF., (2005). Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood.106, 1400-6. 24. Brown VI, Fang J, Alcorn K, Barr R, Kim JM, Wasserman R, Grupp SA., (2003). Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling. Proc Natl AcadSci U S A. 100, 15113-8. 25. Dekkers BG, Pehlic A, Mariani R, Bos IS, Meurs H, Zaagsma J., (2012).Glucocorticosteroids and β₂-adrenoceptor agonists synergize to inhibit airway smooth muscle remodeling. J PharmacolExpTher.342, 780-7. 26. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y., (2000). Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res. 6, 2408-16. 27. Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y and Kim JD., (2000). Constitutive activation of Stat3 signaling. Proc Natl Acad Sci U S A. 97, 4227-32. 28. Siddiquee KAZ, Turkson J., (2008). STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res. 18, 254-67. 29. Guo J, Zhao W, Hao W, Ren G, Lu J, Chen X., 2014. Cucurbitacin B induces DNA damage, G2/M phase arrest, and apoptosis mediated by reactive oxygen species (ROS) in leukemia K562 cells. Anticancer Agents Med Chem. 14, 1146-53. 30. Chan KT, Li K, Liu SL, Chu KH, Toh M, Xie WD., (2010). Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562. Cancer Lett. 289, 46-52. 31. Lin CH, Lu WC, Wang CW, Chan YC, Chen MK., (2013). Capsaicin induces cell cycle arrest and apoptosis in human KB cancer cells. BMC Complement Altern Med. 13, 13:46. 32. Bhutani M, Pathak A K, Sethi G, Aggarwa B B.,(2006). Capsaicin induces G1/S cell cycle arrest leading to apoptosis of multiple myeloma cells through suppression of STAT3 activation and STAT3-regulated gene products. J Clin Oncol. 24, 20039. 33. Mori A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH,Kizaki M, KoefflerHP., (2006).Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res. 66, 3222-9. 34. Zhang W, Ha M, Gong Y, Xu Y, Dong N, Yuan Y., (2010). Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways. Oncol Rep. 24, 1585-92. 35. Schäfer G, Kaschula CH., (2014). The immunomodulation and anti-inflammatory effects of garlic organosulfur compounds in cancer chemoprevention.Anticancer Agents Med Chem. 14, 233-40.
